TP53 Mutations in Myeloid Malignancies are either Homozygous or Hemizygous due to Copy Number-Neutral Loss of Heterozygosity or Deletion of 17p

Ítems similars

• Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
  per: O'Keefe, Christine, et al.
  Publicat: (2010)
• Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
  per: Jankowska, Anna M., et al.
  Publicat: (2009)
• Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
  per: Gondek, Lukasz P., et al.
  Publicat: (2008)
• 250K SNP array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies
  per: Dunbar, Andrew J., et al.
  Publicat: (2008)
• FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8, and del(20q)
  per: Makishima, Hideki, et al.
  Publicat: (2009)